Portfolio Overview

The world's first company that uses artificial intelligence and 3D printing technology to provide customized treatment plans for adult spinal deformities

Exit : IPO on on Nasdaq July, 2025 ; Russell 2000® Index

Building scalable, AI-enabled blood tests that make early cancer detection more accurate, affordable, and widely accessible

Current Stage : Pre - IPO
Exit : Projecting IPO 2026 Q3/Q4

Upright radiotherapy solution with lower cost and fewer side effects on patients

Current Stage: D
Exit : N/A

FDA Cleared 3D, Real Time Endovascular Navigation Technology

Current Stage: Pre-C
Exit : N/A

The New Frontier in Urology — Breakthrough Microbubble SonoLithotripsy that eliminates the need for anesthesia, stents, and the OR in ureteral stone treatment

Current Stage: B Plus
Exit : N/A

Novel wireless, catheter-free urodynamic monitoring system

Current Stage: B plus
Exit : N/A

The New Frontier in Ophthalmic Care Breakthrough technologies for continuous monitoring, diagnosis, and treatment optimization

Current Stage: B
Exit : N/A

Providing revolutionizing respiratory therapy by seamlessly connecting hospital and home environments with advanced technology

Current Stage:Pre-B
Exit : N/A

A breakthrough personalized closed-loop neuromodulation therapy for Alzheimer’s Disease that works by enhancing neuroplasticity via neurostimulation of key brain networks involved in memory

Current Stage: Pre-B
Exit : N/A

FDA‑cleared eWave, a wireless 6‑lead wearable ECG system and digital cardiac monitoring platform that continuously captures heart rhythm data for clinicians and remote diagnosis

Current Stage: Pre-B
Exit : N/A

The First and Only Drill-Free, Patient-Specific, 3D-Printed Dental Implants Placed in Minutes

Current Stage: A
Exit : N/A

The only female thyroid disease telemedicine platform in the U.S.

Current Stage: A
Exit : N/A

Harnessing integrated digital biology and AI to accelerate the discovery of high-value protein therapeutics—democratizing the pharmaceutical industry to defeat disease

Current Stage: A
Exit : Exited

AI-enabled wearable devices that monitor seizures, cardiorespiratory dysfunctions, and SUDEP risk to improve safety and outcomes for people living with epilepsy.

Current Stage: A
Exit : Exited

The First conversational AI platform to accurately and objectively analyze and track patients’ data through facial, speech and movement patterns

Current Stage: A
Exit : N/A

Innovative endovascular catheter platform designed to improve the removal of blood clots in patients suffering from acute ischemic stroke.

Current Stage: A
Exit : N/A

A sustained-release, self-dissolving intravesical drug delivery platform for bladder cancer.

Current Stage: A
Exit : N/A

Google Maps for the Human Body - the autonomous, AI-guided future of surgery

Current Stage: A
Exit : N/A

Developing high-performing low-cost molecular diagnostics

Current Stage: A
Exit : N/A

FDA-cleared ImmersiveView platform transforms a patient's CT and MRI scans into interactive 3D virtual- and augmented-reality models,

Current Stage: A
Exit : N/A

Advancing medical imaging with FDA-cleared AI solutions for CT perfusion denoising, ASL perfusion MRI analysis, and automated radiation therapy contouring.

Current Stage: Pre-A
Exit : N/A

A neurotechnology company developing a minimally invasive, endovascular platform that accesses the brain through the blood vessels to treat neurological conditions without the need for traditional skull-drilling

Current Stage: Pre-A
Exit : N/A

A non-invasive intracranial pressure monitoring device that makes brain pressure assessment as simple as taking your blood pressure — without drilling a hole in the skull

Current Stage: Pre-A
Exit : N/A

A New kind of neural interface using hair-thin, flexible, bioelectronic fibers that seamlessly integrate with the human body

Current Stage: Pre-A
Exit : N/A

The First wearable device for monitoring opioid addiction

Current Stage: Pre-A
Exit : N/A

The first minimally invasive robotic device used in TBM repair surgery.

Current Stage: Pre-A
Exit : N/A

Minimally invasive interbody fusion implantation technology platform

Current Stage: Pre-A
Exit : N/A

FDA Breakthrough Device, a novel vasopressor vasopressor & blood-pressure management platform.

Current Stage: Pre-A
Exit : N/A

Next-generation Endovascular venous valve implant.

Current Stage: Pre-A
Exit : N/A

Providing accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.

Current Stage: Pre-A
Exit : N/A